Document is current
Any future updates will be listed below
-
Authors
Cassier, Philippe A.
Navaridas, Raul https://orcid.org/0000-0003-1622-5311
Bellina, Melanie
Rama, Nicolas https://orcid.org/0000-0003-1614-7755
Ducarouge, Benjamin https://orcid.org/0000-0002-6701-0508
Hernandez-Vargas, Hector https://orcid.org/0000-0001-6045-2103
Delord, Jean-Pierre
Lengrand, Justine
Paradisi, Andrea https://orcid.org/0000-0003-2218-3859
Fattet, Laurent https://orcid.org/0000-0001-5152-4937
Garin, Gwenaële
Gheit, Hanane
Dalban, Cecile
Pastushenko, Ievgenia
Neves, David
Jelin, Remy
Gadot, Nicolas
Braissand, Nicolas
Léon, Sophie
Degletagne, Cyril
Matias-Guiu, Xavier
Devouassoux-Shisheboran, Mojgan
Mery-Lamarche, Eliane
Allard, Justine
Zindy, Egor
Decaestecker, Christine
Salmon, Isabelle
Perol, David
Dolcet, Xavi
Ray-Coquard, Isabelle https://orcid.org/0000-0003-2472-8306
Blanpain, Cédric https://orcid.org/0000-0002-4028-4322
Bernet, Agnès https://orcid.org/0000-0002-8260-9711
Mehlen, Patrick https://orcid.org/0000-0003-1743-5417
- License Information
-
More Information
Article History
Received: 22 April 2022
Accepted: 23 June 2023
First Online: 2 August 2023
Competing interests
: A.B. and P.M. declare a conflict of interest as founders and shareholders of NETRIS Pharma. D.N., B.D., M.B., J.L. and P.M. declare a conflict of interest as employees of NETRIS Pharma. A.B., A.P. and N.R. declare a conflict of interest as consultants for NETRIS Pharma. No patent has been filed based on this study. The NP137 patent is fully owned by NETRIS Pharma and none of the authors are inventors. The remaining authors declare no competing interests.
